L-arginine Effects on Chronic Hypertension in Pregnancy

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the effects of oral L-arginine administration on pregnant women at second trimester of gestation with chronic hypertension, respect with placebo.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Modena and Reggio Emilia
• Collaborator: University of Modena

Criteria

Inclusion Criteria:

• Pregnant women between 18-20 weeks of gestation with chronic hypertension

Exclusion Criteria:

• Other maternal or fetal systemic disease